SMLR — Semler Scientific Inc
NASDAQ · Healthcare · Medical Devices
Semler Scientific Inc (SMLR) is a medical devices company listed on NASDAQ. It is led by Douglas Murphy-Chutorian M.D., based in 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051, with about 79 employees. Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
Latest reported SMLR revenue for 2025-09-30 was $7.5M. Net income was $19.1M. Revenue was down 8.8% from 2025-06-30 to 2025-09-30. SMLR currently screens at market cap $348.3M and trailing P/E 5.0.
Use this SMLR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SMLR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SMLR SEC filings page. Lician reads the product cache first so this HTML stays unique to Semler Scientific Inc even when a live quote feed is slow.
About Semler Scientific Inc
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
SMLR Key Statistics
Market Cap
$348.27M
P/E Ratio
5.04
P/B Ratio
0.68
EPS
$5.13
Revenue
$56.29M
Net Income
$40.90M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-17.4%
Profit Margin
72.7%
Employees
79
SMLR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $56.29M | $68.18M | $56.69M | $53.03M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $40.90M | $20.58M | $14.32M | $17.22M |
| EPS (Diluted) | $5.13 | $2.63 | $1.79 | $2.12 |
Total Assets
$239.83M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$8.82M
Operating Cash Flow
$24.41M
Free Cash Flow
$0.00
Semler Scientific Inc Company Information
- CEO, Interim CFO, President & Director
- Douglas Murphy-Chutorian M.D.
- Headquarters
- 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051
- Website
- www.semlerscientific.com
- Phone
- 877 774 4211
- IPO / Founded
- 2014-02-21
- Sector
- Healthcare
- Industry
- Medical Devices